Estimated 100,429 U.S. Youth Living With Pediatric Inflammatory Bowel Disease
By Elana Gotkine HealthDay Reporter
FRIDAY, Nov. 22, 2024 -- An estimated 100,429 youth are living with pediatric inflammatory bowel disease (PIBD) in the United States, according to a research letter published online Nov. 20 in Gastroenterology.
Michael D. Kappelman, M.D., M.P.H., from the University of North Carolina at Chapel Hill, and colleagues analyzed two commercial insurance claims datasets along with data from five state Medicaid plans to describe the prevalence of PIBD among individuals younger than 20 years.
The researchers found that the age-, sex-, and insurance status-standardized prevalence per 100,000 population was 122 for IBD, 71 for Crohn disease (CD), and 44 for ulcerative colitis (UC). Based on a 2020 U.S. census population, an estimated 100,429 American youth are living with IBD, including 58,733 with CD and 36,270 with UC. All prevalence rates increased with age. The prevalence of CD was higher in males than females. There was variation observed in prevalence by race and ethnicity, with prevalence rates of 145, 91, 52, and 88 per 100,00 population in White, Black, Asian, and Hispanic Americans, respectively. Over time, there was a slight increase seen in PIBD, from 110 per 100,000 in 2011 to 119, 126, and 125 per 100,000 in 2014, 2017, and 2020, respectively.
"These data can be used to inform health policy and resource allocation and suggest the need for future investigation to better understand the causes and consequences of observed differences based on geography, race, and ethnicity," the authors write.
Two authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Guselkumab Efficacious for Moderately to Severely Active Crohn Disease in Adults
THURSDAY, July 24, 2025 -- Intravenous induction followed by subcutaneous maintenance therapy with guselkumab is efficacious for adults with moderately to severely active Crohn...
Digital Model Based on Noninvasive Factors Shows Accuracy for Identifying IBD in Children
TUESDAY, July 22, 2025 -- A model based on noninvasive tests shows high accuracy as a digital tool for the rapid identification of children with inflammatory bowel disease (IBD)...
Healthy Plant-Based Diet May Lower Inflammatory Bowel Disease Risk
WEDNESDAY, July 16, 2025 -- A healthy plant-based diet may reduce the risk for inflammatory bowel disease (IBD) due to the anti-inflammatory properties of the diet, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.